ARCHIVES

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

This article is from The Cancer Letter archive.

Vol. 18 No. 27 | July 3, 1992

Download PDF Visit The Full Archive

Related Articles

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

June 23, 1995

Nutrition May Get An Extra 44 Million In FY 1979; Program Announcement Describes Opportunities

September 22, 1978

HOP Development Proceeding Guidelines For New, Revision Of Existing Control Grants Being Written

July 24, 1981

Also ASCO to release abstracts to members prior to annual meeting.

January 30, 2004

NCI Advisory Group, Other Cancer Meeting

May 26, 1978

NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate

October 22, 1993